Besides tumour perfusion [23] and inhomogeneous distribution of SSTR2, tumour size [17, 22], vessel density, permeability and tumour growth doubling time can play a critical role for the success of PRRT; this is especially true for α-emitters, where the penetration depth in tissue is relatively short (50–100 μm). This evidence concerns the gene SSTR2 and neoplasm.